tiprankstipranks
IDT Australia Limited (AU:IDT)
ASX:IDT
Australian Market

IDT Australia Limited (IDT) Share Price & Analysis

0 Followers

IDT Stock Chart & Stats

Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.05 - AU$0.13
Previous CloseAU$0.1
Volume2.79K
Average Volume (3M)348.44K
Market Cap
AU$35.07M
Enterprise ValueAU$26.74M
Total Cash (Recent Filing)AU$9.21M
Total Debt (Recent Filing)AU$881.00K
Price to Earnings (P/E)-4.7
Beta1.01
Aug 27, 2024
EPS EstimateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding351,479,469
10 Day Avg. Volume180,237
30 Day Avg. Volume348,437
Standard Deviation0.18
R-Squared0.06
Alpha-0.00251
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

6.07%0.00%0.00%93.93%
0.00% Other Institutional Investors
93.93% Public Companies and
Individual Investors

IDT FAQ

What was IDT Australia Limited’s price range in the past 12 months?
IDT Australia Limited lowest share price was AU$0.05 and its highest was AU$0.13 in the past 12 months.
    What is IDT Australia Limited’s market cap?
    Currently, no data Available
    When is IDT Australia Limited’s upcoming earnings report date?
    IDT Australia Limited’s upcoming earnings report date is Aug 27, 2024 which is in 104 days.
      How were IDT Australia Limited’s earnings last quarter?
      IDT Australia Limited released its earnings results on Feb 21, 2024. The company reported -AU$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.011.
        Is IDT Australia Limited overvalued?
        According to Wall Street analysts IDT Australia Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does IDT Australia Limited pay dividends?
          IDT Australia Limited pays a Annually dividend of <AU$0.01 which represents an annual dividend yield of N/A. See more information on IDT Australia Limited dividends here
            What is IDT Australia Limited’s EPS estimate?
            IDT Australia Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does IDT Australia Limited have?
            IDT Australia Limited has 351,479,460 shares outstanding.
              What happened to IDT Australia Limited’s price movement after its last earnings report?
              IDT Australia Limited reported an EPS of -AU$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of IDT Australia Limited?
                Currently, no hedge funds are holding shares in AU:IDT
                ---

                IDT Australia Limited Stock Smart Score

                6
                Neutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Positive
                20 days / 200 days
                Momentum
                20.00%
                12-Months-Change

                Fundamentals

                Return on Equity
                -27.94%
                Trailing 12-Months
                Asset Growth
                8.15%
                Trailing 12-Months

                Company Description

                IDT Australia Limited

                IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
                Avecho Biotechnology Limited
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis